Botanical species · safety record
Cistus monspeliensis
The EFSA Compendium of Botanicals holds 13 constituent measurements for Cistus monspeliensis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Cistus monspeliensis L.
Regulatory presence
No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.
What the records describe
Constituents measured
- Labdane diterpenes5
- Clerodane-type diterpenes4
- (-)-camphor1
- 1,8-cineole1
- Eugenol1
- Gallic acid1
Plant parts
- Leaves6
- Fruit unspecified4
- Aerial part of plants3
Preparations
- Solvent extraction7
- Essential oil6
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Clerodane-type diterpenes | Fruit unspecified | Essential oil | 6.6 Percent | GC-MS | Resolve DOI |
| Clerodane-type diterpenes | Aerial part of plants | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Clerodane-type diterpenes | Leaves | Solvent extraction | 50 Percent | GC-MS | Resolve DOI |
| Clerodane-type diterpenes | Fruit unspecified | Solvent extraction | 62.5 Percent | GC-MS | Resolve DOI |
| Labdane diterpenes | Fruit unspecified | Essential oil | 6.6 Percent | GC-MS | Resolve DOI |
| Labdane diterpenes | Leaves | Solvent extraction | 16.6 Percent | GC-MS | Resolve DOI |
| Labdane diterpenes | Fruit unspecified | Solvent extraction | 25 Percent | GC-MS | Resolve DOI |
| Labdane diterpenes | Leaves | Essential oil | 15.38 Percent | GC-MS | Resolve DOI |
| Labdane diterpenes | Aerial part of plants | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| (-)-camphor | Leaves | Essential oil | 1.5 Percent | GC-MS | No resolvable identifier |
| 1,8-cineole | Leaves | Essential oil | 8.8 Percent | GC-MS | No resolvable identifier |
| Eugenol | Leaves | Essential oil | 1.5 Percent | GC-MS | No resolvable identifier |
| Gallic acid | Aerial part of plants | Solvent extraction | 8.14 Milligram/gram | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Angelopoulou, D., Demetzos, C., Dimas, C., Perdetzoglou, D., Loukis, A. Essential oils and hexane extracts from leaves and fruits of Cistus monspeliensis. Cytotoxic activity of ent-13-epi-manoyl oxide and its isomers . Planta medica, 2001, vol. 67, no. 2, p. 168-171. DOI
- Viuda-Martos, Manuel., Sendra, Esther., Perez-Alvarez, Jose A., Fernandez-Lopez, Juana., Amensour, Mahassine., Abrini, Jamal. Identification of Flavonoid Content and Chemical Composition of the Essential Oils of Moroccan Herbs: Myrtle (Myrtus communis L.), Rockrose (Cistus ladanifer L.) and Montpellier cistus (Cistus monspeliensis L.) . Journal of essential oil research, 2011, vol. 23, no. 2, p. 1-9.
- Fokialakis, Nikolas., Kalpoutzakis, Eleftherios., Tekwani, Babu Lal., Skaltsounis, Alexios Leandros., Duke, Stephen Oscar. Antileishmanial activity of natural diterpenes from Cistus sp and semisynthetic derivatives thereof. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, vol. 29, no. 8, p. 1775-1778. DOI
- Santagati, Natale Alfredo., Salerno, Loredana., Attaguile, Giuseppina., Savoca, Francesca., Ronsisvalle, Giuseppe. Simultaneous determination of catechins, rutin, and gallic acid in Cistus species extracts by HPLC with diode array detection. JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2008, vol. 46, no. 2, p. 150-156.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.